Apple faces patent ‘problem’ over Apple Watch – Times of India



In 2020, Masimo, a medical technology company, filed a lawsuit against Apple over the blood oxygen monitoring capabilities of the Watch Series 6. The company accused the Cupertino-based tech giant of infringing on 10 of its pulse oximeter patents with the launch of Apple Watch Series 6 that year.
Apple found ‘guilty’ of patent infringement
Now, the US International Trade Commission (ITC) found Apple guilty of infringing one of Masino’s pulse oximeter patents, considering forbidding the import of Apple Watches Series 6 and newer models.
The ITC judge has concluded that Apple did not infringe the other nine patents that the Cupertino giant was accused of. However, the judge ruled out that Apple ‘indeed’ infringed one patent with the launch of Watch Series 6 with light-based pulse oximetry.
Masimo describes itself as “the inventors of modern pulse oximeters,” and its tech is used in many hospital equipment.
Apple Watch 6 and newer models could soon be banned in the US
The matter has been passed on to the International Trade Commission, which will now consider whether to impose an import ban on Apple Watches, on the request of Masimo.
The decision will affect the Watch Series 6 and later, including the newer Apple Watch SE 2 and Watch Ultra, as these come with blood oxygen monitoring features.
The final judgement is expected to be concluded by May 10.
Masimo accuses Apple of poaching and stealing trade secrets
Apple and Masimo have a long history. In 2013, Apple attempted to form a partnership with Masimo. However, the CEO of the medical technology company says that Apple intended to poach its employees.
Later in 2013, Apple successfully recruited several employees from Masimo, including its chief medical officer, offering them large salaries. These individuals had access to trade secrets and confidential information belonging to the company.
In 2020, Masimo sued Apple for stealing trade secrets, seeking a ban on the sale of Apple Watches in the US. Then a year later, the company alleged the Cupertino giant of infringing patents.





Source link